XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

EARNINGS PER COMMON SHARE | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
EARNINGS PER COMMON SHARE | EARNINGS PER COMMON SHARE The following table reconciles the numerators and denominators of our basic and diluted earnings per common share calculations. Net income available to our common shareholders is expressed in millions and weighted average shares are expressed in thousands.
|  | Net Income Available to Common Shareholders (Numerator) |  | Weighted Average Shares (Denominator) |  | Per-Share Amount
Three Months Ended September 30, 2025 |  |  |  |  |  |
Net income available to Tenet Healthcare Corporation common shareholders for basic earnings per share |  | $ | 342 |  |  | 87,951 |  |  | $ | 3.89 |
Effect of dilutive instruments |  | — |  |  | 659 |  |  | (0.03) |
Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share |  | $ | 342 |  |  | 88,610 |  |  | $ | 3.86 |
Three Months Ended September 30, 2024 |  |  |  |  |  |
Net income available to Tenet Healthcare Corporation common shareholders for basic earnings per share |  | $ | 472 |  |  | 95,665 |  |  | $ | 4.93 |
Effect of dilutive instruments |  | 1 |  |  | 987 |  |  | (0.04) |
Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share |  | $ | 473 |  |  | 96,652 |  |  | $ | 4.89 |
Nine Months Ended September 30, 2025 |  |  |  |  |  |
Net income available to Tenet Healthcare Corporation common shareholders for basic earnings per share |  | $ | 1,036 |  |  | 91,109 |  |  | $ | 11.37 |
Effect of dilutive instruments |  | — |  |  | 696 |  |  | (0.09) |
Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share |  | $ | 1,036 |  |  | 91,805 |  |  | $ | 11.28 |
Nine Months Ended September 30, 2024 |  |  |  |  |  |
Net income available to Tenet Healthcare Corporation common shareholders for basic earnings per share |  | $ | 2,882 |  |  | 97,505 |  |  | $ | 29.56 |
Effect of dilutive instruments |  | 2 |  |  | 1,013 |  |  | (0.29) |
Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share |  | $ | 2,884 |  |  | 98,518 |  |  | $ | 29.27 |
Dilutive instruments during the three and nine months ended September 30, 2025 and 2024 consisted of stock options, RSUs, convertible long‑term incentive awards, deferred compensation units and dividends on subsidiary preferred stock. During the nine-month period in 2024, our dilutive instruments also included RSUs issued under USPI’s restricted stock plan.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration